Al-Salameh, Abdallah http://orcid.org/0000-0002-7951-9926
Cadiot, Guillaume
Calender, Alain
Goudet, Pierre
Chanson, Philippe http://orcid.org/0000-0001-5096-5722
Article History
Accepted: 7 January 2021
First Online: 9 February 2021
Competing interests
: A.A.-S. has worked as sub-investigator for Alnylam Pharmaceuticals, Ionis (Isis) Pharmaceuticals, Novartis, MedDay Pharmaceuticals, Auris Medical, Gilead Sciences, Euroscreen (Ogeda), Alexion, Faron Pharmaceuticals, Actelion (Idorsia) Pharmaceuticals and IPSEN. G.C. is member of advisory boards of AAA, Keocyt, Ipsen, Novartis and Pfizer. P.G. received research grant from IPSEN. P.C. has received unrestricted research and educational grants from Ipsen, Novartis, Novo-Nordisk and Pfizer as Head of the Department of Endocrinology and Reproductive Diseases, APHP Paris-Saclay. P.C. has served as investigator (principal or coordinator) for clinical trials funded by Novartis, Pfizer, Ipsen, Antisense and Prolor Biotech. P.C. is a member of advisory boards from Ipsen, Novartis, Pfizer and Tiburio. P.C. gave lectures for Ipsen, Novartis and Pfizer. All the fees and honoraria are paid to his Institution. A.C. declares no competing interests.